🇺🇸 FDA
Patent

US 10407488

Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation

granted A61KA61K38/36A61K38/4846

Quick answer

US patent 10407488 (Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation) held by The Regents of the University of California expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/36, A61K38/4846, A61K45/06, A61P